Patents by Inventor Mark M. Ross

Mark M. Ross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cytotoxic T-Lymphocyte-Inducing Immunogens for Prevention, Treatment and Diagnosis of Cancer
    Publication number: 20110142919
    Abstract: The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, especially carcinomas, such as ovarian carcinoma. The invention discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a CTL response against cancer.
    Type: Application
    Filed: February 18, 2011
    Publication date: June 16, 2011
    Applicant: Immunotope, Inc.
    Inventors: Venky Ramakrishna, Mark M. Ross, Ramila Philip
  • Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
    Patent number: 7919467
    Abstract: The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, especially carcinomas, such as ovarian carcinoma. The invention discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a CTL response against cancer.
    Type: Grant
    Filed: June 23, 2006
    Date of Patent: April 5, 2011
    Assignee: Immunotope, Inc.
    Inventors: Venky Ramakrishna, Mark M. Ross, Ramila Philip, Lorraine H. Keller
  • CYTOTOXIC T-LYMPHOCYTE-INDUCING IMMUNOGENS FOR PREVENTION, TREATMENT, AND DIAGNOSIS OF CANCER
    Publication number: 20080207497
    Abstract: The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, especially carcinomas, such as ovarian carcinoma. The invention discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a CTL response against cancer.
    Type: Application
    Filed: June 23, 2006
    Publication date: August 28, 2008
    Applicant: Immunotope, Inc.
    Inventors: Venky Ramakrishna, Mark M. Ross, Ramila Philip, Lorraine H. Keller
  • Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
    Patent number: 7083789
    Abstract: The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, especially carcinomas, such as ovarian carcinoma. The invention discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a CTL response against cancer.
    Type: Grant
    Filed: December 4, 2001
    Date of Patent: August 1, 2006
    Assignee: Immunotope, Inc.
    Inventors: Venky Ramakrishna, Mark M. Ross, Ramila Philip
  • Phosphorylated proteins and uses related thereto
    Publication number: 20030232014
    Abstract: Methods and systems of applying mass spectrometry to the analysis of peptides and amino acids, especially in the proteome setting. More particularly, the invention relates to a mass spectrometry-based method for detection of amino acid modifications, such as phosphorylation.
    Type: Application
    Filed: March 3, 2003
    Publication date: December 18, 2003
    Applicants: MDS Proteomics Inc., University of Virginia
    Inventors: Daniel J. Burke, Mark M. Ross, P. Todd Stukenberg, Forest M. White
  • Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
    Publication number: 20030165513
    Abstract: The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, especially carcinomas, such as ovarian carcinoma. The invention discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a CTL response against cancer.
    Type: Application
    Filed: December 4, 2001
    Publication date: September 4, 2003
    Inventors: Venky Ramakrishna, Mark M. Ross, Ramila Philip
  • MHC class I associated peptides for prevention and treatment of tuberculosis
    Publication number: 20020192229
    Abstract: The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of tuberculosis, and discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a CTL response against tuberculosis. The peptide and/or proteins of the invention may be used as a therapeutic drug to stimulate the immune system to recognize and eliminate M. tuberculosis in infected cells or as a vaccine for the prevention of disease. Antibodies that react with the immunogens of the invention, as well as methods of using these antibodies for prevention and treatment of disease, are also disclosed.
    Type: Application
    Filed: December 13, 2001
    Publication date: December 19, 2002
    Inventors: David Flyer, Mark M. Ross, Donald F. Hunt, Forest M. White, Victor H. Engelhard, Ramila Philip
  • C-ski oncogene-derived peptides for prevention, treatment, and diagnosis of cancer
    Publication number: 20020137683
    Abstract: The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, specifically malignant melanoma, colorectal carcinoma, ovarian carcinoma, lung carcinoma, and prostate carcinoma. The invention discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a CTL response against cancer, and more specifically malignant melanoma, colorectal carcinoma, ovarian carcinoma, lung carcinoma, and prostate carcinoma.
    Type: Application
    Filed: January 3, 2001
    Publication date: September 26, 2002
    Inventors: Kevin T. Hogan, Mark M. Ross